ATE366728T1 - Synthese von für die herstellung von pde-iv- inhibitoren geeigneten chinolin-5-carboxamiden - Google Patents

Synthese von für die herstellung von pde-iv- inhibitoren geeigneten chinolin-5-carboxamiden

Info

Publication number
ATE366728T1
ATE366728T1 AT04788707T AT04788707T ATE366728T1 AT E366728 T1 ATE366728 T1 AT E366728T1 AT 04788707 T AT04788707 T AT 04788707T AT 04788707 T AT04788707 T AT 04788707T AT E366728 T1 ATE366728 T1 AT E366728T1
Authority
AT
Austria
Prior art keywords
pde
quinoline
inhibitors
synthesis
production
Prior art date
Application number
AT04788707T
Other languages
English (en)
Inventor
David Andrews
Suhan Tang
Wenxue Wu
Sami Kalliney
Anantha Sudhakar
Christopher Nielsen
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE366728T1 publication Critical patent/ATE366728T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632Organic additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ceramic Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Pulmonology (AREA)
  • Structural Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04788707T 2003-09-15 2004-09-13 Synthese von für die herstellung von pde-iv- inhibitoren geeigneten chinolin-5-carboxamiden ATE366728T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50310803P 2003-09-15 2003-09-15

Publications (1)

Publication Number Publication Date
ATE366728T1 true ATE366728T1 (de) 2007-08-15

Family

ID=34375311

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04788707T ATE366728T1 (de) 2003-09-15 2004-09-13 Synthese von für die herstellung von pde-iv- inhibitoren geeigneten chinolin-5-carboxamiden

Country Status (12)

Country Link
US (1) US7129357B2 (de)
EP (1) EP1664024B1 (de)
JP (1) JP2007505834A (de)
CN (1) CN1878765A (de)
AT (1) ATE366728T1 (de)
CA (1) CA2538591A1 (de)
DE (1) DE602004007531T2 (de)
ES (1) ES2286685T3 (de)
HK (1) HK1084398A1 (de)
MX (1) MXPA06002917A (de)
WO (1) WO2005028471A1 (de)
ZA (1) ZA200602155B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283162B6 (sk) * 1996-05-20 2003-03-04 Darwin Discovery Limited Karboxamid chinolínu ako inhibítor faktora nekrotizujúceho nádor, inhibítor fosfodiesterázy-IV a farmaceutický prostriedok s jeho obsahom
US6262070B1 (en) * 1998-11-04 2001-07-17 Darwin Discovery Ltd. Heterocyclic compounds and their therapeutic use
GB9824160D0 (en) * 1998-11-04 1998-12-30 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
US6211243B1 (en) * 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions

Also Published As

Publication number Publication date
DE602004007531D1 (de) 2007-08-23
EP1664024B1 (de) 2007-07-11
WO2005028471A1 (en) 2005-03-31
JP2007505834A (ja) 2007-03-15
CA2538591A1 (en) 2005-03-31
MXPA06002917A (es) 2006-05-31
CN1878765A (zh) 2006-12-13
US7129357B2 (en) 2006-10-31
EP1664024A1 (de) 2006-06-07
US20050124655A1 (en) 2005-06-09
ES2286685T3 (es) 2007-12-01
HK1084398A1 (en) 2006-07-28
ZA200602155B (en) 2007-09-26
DE602004007531T2 (de) 2008-03-13

Similar Documents

Publication Publication Date Title
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
UA89390C2 (ru) Способ получения аннелированных производных пиперазин-2-она та соответствующие промежуточные продукты
CR9221A (es) Procesos para preparar eteres aromaticos
MY150538A (en) Process for the manufacture of dihydropteridinones
UA95600C2 (en) Synthesis scheme for lacosamide
ATE447564T1 (de) Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE402173T1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
ATE449069T1 (de) Aminopropanolderivate
DE602006010584D1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
TW200612959A (en) Method for preparing hydroxamic acids
DE502004001922D1 (de) Verfahren zur herstellung von ethylenaminen
SE0403085D0 (sv) Novel componds
ATE529413T1 (de) Verfahren zur synthese von aryloxydiaminopyrimidinen
ATE388154T1 (de) Kristalline form von cefdinir-ammoniumsalz als zwischenprodukt für die herstellung von reinem cefdinir
ATE344259T1 (de) Verfahren und zwischenprodukte für die herstellung von emtricitabin
BR0214445B1 (pt) processos para a produção de compostos.
DE60238030D1 (de) Katalysatorzusammensetzung für die Herstellung von Polyolefinen
ATE366728T1 (de) Synthese von für die herstellung von pde-iv- inhibitoren geeigneten chinolin-5-carboxamiden
CY1112457T1 (el) Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων
DE60106778D1 (de) Verfahren zur herstellung von vitronectin-rezeptorantagonisten
UA91153C2 (ru) Способ получения формы и венлафаксина гидрохлорида

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties